JP2006503049A - ソルビシルラクトンａおよびソルビシルラクトンａ誘導体、これらの製造方法、これらを含有する薬剤、およびこれらの使用 - Google Patents

ソルビシルラクトンａおよびソルビシルラクトンａ誘導体、これらの製造方法、これらを含有する薬剤、およびこれらの使用 Download PDF

Info

Publication number
JP2006503049A
JP2006503049A JP2004536901A JP2004536901A JP2006503049A JP 2006503049 A JP2006503049 A JP 2006503049A JP 2004536901 A JP2004536901 A JP 2004536901A JP 2004536901 A JP2004536901 A JP 2004536901A JP 2006503049 A JP2006503049 A JP 2006503049A
Authority
JP
Japan
Prior art keywords
compound
lactone
alkyl
pharmaceutical composition
sorbicil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004536901A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006503049A5 (OSRAM
Inventor
ブリングマン，ゲルハルド
ラング，ゲルハルド
ミュールバッカー，イェーグ
シャウマン，カルステン
シュテッフェンス，シュテファン
ミュラー，ウェルネル，エー．，ゲー．
Original Assignee
ヨハンネス グーテンベルク−ウニヴェルズィテート マインツ
フライシュタート バイアーン フェアトレーテン ドゥルヒ ディ ユリウス−マクスィミーリアーン−ウニ ヴェルズィテート ヴュルツブルク
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヨハンネス グーテンベルク−ウニヴェルズィテート マインツ, フライシュタート バイアーン フェアトレーテン ドゥルヒ ディ ユリウス−マクスィミーリアーン−ウニ ヴェルズィテート ヴュルツブルク filed Critical ヨハンネス グーテンベルク−ウニヴェルズィテート マインツ
Publication of JP2006503049A publication Critical patent/JP2006503049A/ja
Publication of JP2006503049A5 publication Critical patent/JP2006503049A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
JP2004536901A 2002-08-21 2003-07-17 ソルビシルラクトンａおよびソルビシルラクトンａ誘導体、これらの製造方法、これらを含有する薬剤、およびこれらの使用 Withdrawn JP2006503049A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10238257A DE10238257B4 (de) 2002-08-21 2002-08-21 Sorbicillacton A und Sorbicillacton-A-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
PCT/EP2003/007805 WO2004026854A1 (de) 2002-08-21 2003-07-17 Sorbicillacton-a-derivate zur behandlung von tumor- und viruserkrankungen

Publications (2)

Publication Number Publication Date
JP2006503049A true JP2006503049A (ja) 2006-01-26
JP2006503049A5 JP2006503049A5 (OSRAM) 2006-07-27

Family

ID=31501834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004536901A Withdrawn JP2006503049A (ja) 2002-08-21 2003-07-17 ソルビシルラクトンａおよびソルビシルラクトンａ誘導体、これらの製造方法、これらを含有する薬剤、およびこれらの使用

Country Status (9)

Country Link
US (1) US20060111420A1 (OSRAM)
EP (1) EP1532129B1 (OSRAM)
JP (1) JP2006503049A (OSRAM)
AT (1) ATE346057T1 (OSRAM)
AU (1) AU2003250985A1 (OSRAM)
CA (1) CA2496386A1 (OSRAM)
DE (2) DE10238257B4 (OSRAM)
WO (1) WO2004026854A1 (OSRAM)
ZA (1) ZA200502226B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11139542B2 (en) 2015-12-02 2021-10-05 Sk Innovation Co., Ltd. Separator for secondary cell having excellent heat resistance and shutdown properties

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004004901B4 (de) * 2004-01-30 2006-01-05 Johannes-Gutenberg-Universität Mainz Verfahren zur Herstellung von Sorbicillacton A
DE102004005106A1 (de) * 2004-02-02 2005-08-18 Johannes-Gutenberg-Universität Mainz Sorbifuranone, Sorbivineton, Sorbivinetol und Derivate dieser Verbindungen, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung
CN110037054B (zh) * 2019-04-16 2021-04-20 云南大学 一种提高烟草抗病性的水溶性多肽诱导剂及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ332340A (en) * 1996-05-20 2000-04-28 Darwin Discovery Ltd 4-(aryl or heteroaryl) substituted benzofurancarboxamide derivatives and medicaments
AU2001293048A1 (en) * 2000-09-26 2002-04-08 The Johns Hopkins University Antiviral compositions and methods of use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11139542B2 (en) 2015-12-02 2021-10-05 Sk Innovation Co., Ltd. Separator for secondary cell having excellent heat resistance and shutdown properties

Also Published As

Publication number Publication date
EP1532129A1 (de) 2005-05-25
EP1532129B1 (de) 2006-11-22
ZA200502226B (en) 2006-02-22
AU2003250985A1 (en) 2004-04-08
US20060111420A1 (en) 2006-05-25
DE10238257A1 (de) 2004-03-11
DE10238257B4 (de) 2007-04-19
ATE346057T1 (de) 2006-12-15
WO2004026854A1 (de) 2004-04-01
DE50305776D1 (de) 2007-01-04
CA2496386A1 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
Schaffner-Sabba et al. . beta.-Lapachone: synthesis of derivatives and activities in tumor models
CA2259621C (en) Isocoumarin derivatives and their use in medicines
OKAMOTO et al. Studies of platelet activating factor (PAF) antagonists from microbial products. I.: bisdethiobis (methylthio) gliotoxin and its derivatives
JP2003522166A (ja) 抗腫瘍活性を有する化合物：その製法およびそれを含有する医薬組成物
JP2006503049A (ja) ソルビシルラクトンａおよびソルビシルラクトンａ誘導体、これらの製造方法、これらを含有する薬剤、およびこれらの使用
AU689912B2 (en) Bioactive acetogenins and derivatives
JPWO2013157555A1 (ja) 新規アプリシアトキシン誘導体及びそれを含有する抗がん剤
MC1708A1 (fr) Composes polycycliques biocides,procedes et intermediaires pour leur synthese et preparations pharmaceutiques les contenant
EP1297835B1 (fr) Dérivés de benzo[b]pyrano[3,2-h]acridin-7-one, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US5091412A (en) Novel antiviral terpene hydroquinones and methods of use
AU759990B2 (en) Dithiolopyrrolones and their corresponding monoxides and dioxides as antineoplastic agents
JPWO2003006060A1 (ja) Ｓｈ３ドメイン結合阻害剤
US5204367A (en) Novel antiviral and anti-leukemia terpene hydroquinones and methods of use
FR2973376A1 (fr) Derives utiles dans le traitement ou la prevention de tumeurs osseuses
US5051519A (en) Novel antiviral and antitumor terpene hydroquinones and methods of use
US3547911A (en) Synthesis of antheridiol and its derivatives
JP2004534756A (ja) 海綿共生カビ由来の新規デカラクトン類および医薬品としてのそれらの合成誘導体類
EP1674101B1 (fr) Dérivés cinnamates de benzo [b]pyrano[3,2-h]acridin-7-one, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
JP3875024B2 (ja) ヒト免疫不全ウイルス（ｈｉｖ）増殖を抑制する新規生理活性物質
US5180748A (en) Avarone and its pharmaceutical compositions and use as an antiviral agent
JP4452787B2 (ja) 新規発酵生産物
CN115990155A (zh) 溴代嗜氮酮类化合物在制备破骨细胞分化抑制剂上的应用
EP0275307A1 (en) Antitumor compositions and their methods of use
JPH10147551A (ja) ヒドロナフタレン誘導体を有効成分とする抗炎症剤、抗癌剤及び新規ヒドロナフタレン誘導体
JPH07149631A (ja) アルドースレダクターゼ阻害剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060606

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060606

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070329

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20080404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080624

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080812